Hence, the activity of Tip60 appears to rely on the specific context (cellular or molecular), and aberrations in lysine acetyltransferase activity can either promote or impede tumorigenesis in colon, breast, and prostate cancers [145]. This evidence concerns the gene KAT5 and prostate carcinoma.